NDC 16729-275 – Bivalirudin

Bivalirudin 250 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug 1 recall

Product NDC16729-275

Product details

Brand name
Bivalirudin
Generic name
Bivalirudin
Labeler
Accord Healthcare, Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
ANDA · ANDA206551
Marketed since
November 7, 2018
Listing expires
December 31, 2026
Pharmacologic class
Anti-coagulant; Direct Thrombin Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Bivalirudin →

Package NDC codes (1)

Package NDCDescriptionSince
16729-275-6710 VIAL, SINGLE-USE in 1 CARTON (16729-275-67) / 5 mL in 1 VIAL, SINGLE-USE (16729-275-03)Nov 7, 2018

Recalls mentioning this NDC

Other Bivalirudin products